Skip to main content
Earnings Labs
Insmed Incorporated logo

Insmed Incorporated (INSM)

NASDAQ·Healthcare·Biotechnology

$102.86

-1.14%

Mkt Cap $23.18B

Analyst Ratings

Buy

23

Hold

0

Sell

0

Price Target (65 analysts)

$204.42

Range $160.00$245.00

Implied Upside

+98.7%

Consensus $204.42 vs current $102.86